ArticleActa oncologica (Stockholm, Sweden)2025

Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study.

Ali Inan El-Naggar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.